Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection
SARS-CoV-2 감염 후 항인자 H 항체 관련 용혈성 요독 증후군
Case Reports
[키워드] Abnormalities
Abstract
Alternative complement pathway
antibody
Atypical
autoantibody
CFHR1
Chain Reaction
complement
Complement factor H related protein
consecutive patient
Coronavirus 19
cut-off
Cyclophosphamide
dialysis
disease
episode of
estimated glomerular filtration rate
Factor
Factor H
febrile illness
filtration rate
Follow-up
Genetic
Genetic studies
glomerular filtration rate
hemolytic uremic syndrome
homozygous
Increased
information
initial
management
median
median titer
mycophenolate
mycophenolate mofetil
New
one patient
pandemic
Pathogenesis
Patient
patients
plasma
plasma exchanges
polymerase chain
polymerase chain reaction
Prednisolone
ranged
required
respiratory
respiratory symptom
respiratory symptoms
reverse transcriptase
Reverse transcriptase polymerase chain reaction
RT-PCR
SARS-CoV-2
SARS-COV-2 infection
screened
serology
Specific
thrombotic microangiopathy
transcriptase
Trigger
triggered
uremic syndrome
[DOI] 10.1007/s00467-021-05390-4 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1007/s00467-021-05390-4 PMC 바로가기 [Article Type] Case Reports